• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

SGLT-2 inhibitors not associated with increased risk for severe UTI

byCaitlyn HuiandDeepti Shroff Karhade
July 31, 2019
in Chronic Disease, Endocrinology, Infectious Disease
Reading Time: 2 mins read
1
Share on FacebookShare on Twitter

1. No significant difference in severe UTIs was observed between patients starting SGLT-2 inhibitors for type 2 diabetes, compared to DPP-4 inhibitors or GLP-1 agonists.

Evidence Rating Level: 2 (Good)

Study Rundown: The sodium glucose cotransporter-2 (SGLT-2) inhibitors are a newer class of diabetic medications that act by inhibiting glucose reabsorption in the proximal tubule, thereby reducing serum glucose levels. Since SGLT-2 inhibitors increase the availability of glucose in the urinary tract, there is concern the mechanism might promote bacterial growth. Studies have suggested that SGLT-2 inhibitors increase the risk of mild and moderate urinary tract infections (UTIs); however, findings are currently conflicting. This study utilized two large databases of U.S. commercial claims. The primary aim was to assess whether the initiation of SLGT-2 inhibitor therapy was associated with increased risk for severe UTIs. Inclusion criterion consisted of patients with type 2 diabetes, ages 18 or older, and had initiated SGLT-2 use, versus DPP-4 inhibitors or GLP-1 agonists. The study found that SGLT-2 inhibitors were not associated with increased risk for severe UTI compared with other anti-diabetic medications.. One limitation of this study was that the patient cohort was restricted to those with commercial insurance; therefore, the study results may not be fully generalizable to other patient groups.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Dose response of sodium glucose cotransporter-2 inhibitors in relation to urinary tract infections: a systematic review and network meta-analysis of randomized controlled trials

In-Depth [retrospective cohort study]: A population-based cohort study was conducted to assess the relationship between SGLT-2 inhibitors and frequency of UTIs compared to other diabetic medications. Data was retrieved from 2 large U.S. based databases of commercial claims from March 2013 to September 2015. There were two main cohorts of patients. In the first cohort, patients starting SGLT-2 inhibitors were compared with those starting a dipeptidyl peptidase-4 (DPP-4) inhibitor. The second cohort included patients starting use of an SGLT-2 inhibitor compared to a glucagon-like peptide-2 receptor (GLP-1) agonist. Patients at high risk of UTI development were excluded from the study.  Following inclusion and exclusion criteria, cohort 1 consisted of 86 665 patients using SGLT-2 inhibitors and 136 741 patients using DPP-4 inhibitors; cohort 2 consisted of 107 289 patients using SGLT-2 inhibitors and 67 871 patients using GLP-1 agonists. Logistic regression was utilized to calculate propensity scores. After propensity scores were calculated, the SGLT-2 inhibitor group resulted in 61 severe UTI events (IR, 1.76 cases per 1000 person-years) compared to 59 in the DPP-4 inhibitor group (IR, 1.77 cases per 1000 person-years). These values correspond to an adjusted HR of 0.98 (CI, 0.68 to 1.41). Similarly, there were 73 events in the SGLT-2 inhibitor group IIR, 2.15 cases per 1000 person-years) and 87 events in the GLP-1 agonist group in cohort 2 (IR, 2.96 cases per 1000 person years), resulting in a HR of 0.72 (CI, 0.53 to 0.99).

Image: PD

RELATED REPORTS

The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]

Increases in muscle-strengthening activities may reduce mortality risk and certain diseases

Associations of dietary patterns and lifestyle modifications with glycemic control in diabetic patients

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetesDPP-4 inhibitorsGLP-1 agonistSGLT-2 inhibitorsurinary tract infection (UTI)
Previous Post

#VisualAbstract: Social Robots for Hospitalized Children

Next Post

Quick Take: The state of hypertension care in 44 low-income and middle-income countries

RelatedReports

Classics Series, Landmark Trials in Medicine
Emergency Classics

The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]

May 4, 2022
Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors
Cardiology

Increases in muscle-strengthening activities may reduce mortality risk and certain diseases

May 3, 2022
Chronic Disease

Associations of dietary patterns and lifestyle modifications with glycemic control in diabetic patients

April 29, 2022
Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants
Chronic Disease

Oral tebipenem pivoxil hydrobromide is effective in treatment of complicated urinary tract infection

April 22, 2022
Next Post
Blood pressure variability associated with cardiovascular disease and mortality

Quick Take: The state of hypertension care in 44 low-income and middle-income countries

No survival benefit with ICDs in non-ischemic systolic heart failure: The DANISH trial

Cardiac device implantation complications vary widely among hospitals

Warning labels on sugar-sweetened beverages impact parent decisions

2 Minute Medicine Rewind July 15, 2019

Please login to join discussion

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
  • Operating the day after performing surgery the previous night not associated with adverse patient outcomes
  • Gratitude-focused writing may improve mental wellness during periods of chronic stress
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.